{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T05:44:05Z","timestamp":1787031845403,"version":"build-2736575974"},"reference-count":34,"publisher":"SAGE Publications","issue":"4","license":[{"start":{"date-parts":[[2016,12,16]],"date-time":"2016-12-16T00:00:00Z","timestamp":1481846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Ophthalmology"],"published-print":{"date-parts":[[2017,6,26]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>To determine the potential role of intraoperative dexamethasone intravitreal implant (DEX-I) in reducing diabetic macular edema (DME) worsening after phacoemulsification.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This was a prospective study on 19 eyes of 19 patients with type 2 diabetes mellitus with DME and cataract. Mean preoperative Early Treatment Diabetic Retinopathy Study visual acuity (VA) was 16.7 letters. Mean foveal thickness (FT) was 451 \u03bcm. The DME was naive in 11 eyes and refractory in 8 eyes. All eyes underwent a standard phacoemulsification and intraocular lens implantation; DEX-I was injected at the end of surgery. Follow-up was performed at 1 week and then monthly until DME recurrence (up to 8 months).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>At 1 week, mean VA improved by 15 letters (range 0-29 letters) and mean FT decreased by 147 \u03bcm (range 69-236 \u03bcm). Improvement consolidated at month 1, with a mean VA improvement of 18 letters (range 3-32 letters) and a mean improvement in FT of 193 \u03bcm (range 76-304 \u03bcm), remaining stable at month 2 after surgery in all eyes. The DME recurred in 1 eye at month 3, in 14 eyes (73.8%) between months 4 and 5, and after month 6 in 4 eyes (21%). Refractory DMEs demonstrated the same benefit but recurred earlier than naive ones (4 months versus 5.8 months, p&lt;0.01).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Intraoperative DEX-I prevents DME worsening after phacoemulsification. Its positive effects last for at least 3 months.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.5301\/ejo.5000920","type":"journal-article","created":{"date-parts":[[2016,12,23]],"date-time":"2016-12-23T07:47:07Z","timestamp":1482479227000},"page":"433-437","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":35,"title":["Dexamethasone Intravitreal Implant at the Time of Cataract Surgery in Eyes with Diabetic Macular Edema"],"prefix":"10.1177","volume":"27","author":[{"given":"Giacomo A.","family":"Panozzo","sequence":"first","affiliation":[{"name":"Ophthalmology Unit, Bussolengo Hospital, Bussolengo (Verona) - Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Gusson","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University of Medicine, Verona - Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Panozzo","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Parma, Parma - Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Dalla Mura","sequence":"additional","affiliation":[{"name":"Ophthalmology Unit, Bussolengo Hospital, Bussolengo (Verona) - Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2016,12,16]]},"reference":[{"key":"bibr1-ejo.5000920","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(14)71170-5"},{"key":"bibr2-ejo.5000920","doi-asserted-by":"publisher","DOI":"10.3109\/09286589509071451"},{"key":"bibr3-ejo.5000920","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.87.9.1112"},{"key":"bibr4-ejo.5000920","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2003.038380"},{"key":"bibr5-ejo.5000920","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.10-5414"},{"key":"bibr6-ejo.5000920","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-3768.2011.02326.x"},{"key":"bibr7-ejo.5000920","doi-asserted-by":"publisher","DOI":"10.4239\/wjd.v6.i1.92"},{"key":"bibr8-ejo.5000920","volume-title":"Management of diabetic retinopathy","author":"Hamilton AMP"},{"issue":"100027","key":"bibr9-ejo.5000920","first-page":"1513","volume-title":"Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4\u00b74 million participants. Lancet","volume":"387","year":"2016"},{"issue":"7","key":"bibr10-ejo.5000920","first-page":"870","volume":"131","author":"Baker CW","year":"2013","journal-title":"Macular edema after cataract surgery in eyes without preoperative central-involved diabetic macular edema. JAMA Ophthalmol"},{"key":"bibr11-ejo.5000920","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(99)90148-3"},{"issue":"1","key":"bibr12-ejo.5000920","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jfo.2012.03.008","volume":"36","author":"Giocanti-Aur\u00e9gan A","year":"2013","journal-title":"J Fr Ophtalmol"},{"key":"bibr13-ejo.5000920","doi-asserted-by":"publisher","DOI":"10.1177\/112067219900900103"},{"key":"bibr14-ejo.5000920","doi-asserted-by":"publisher","DOI":"10.1016\/S0886-3350(01)01142-7"},{"key":"bibr15-ejo.5000920","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.75.9.547"},{"key":"bibr16-ejo.5000920","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.80.9.789"},{"issue":"6","key":"bibr17-ejo.5000920","first-page":"831","volume":"111","author":"Chylack LT","year":"1993","journal-title":"The lens opacities classification system III. Arch Ophthalmol"},{"key":"bibr18-ejo.5000920","doi-asserted-by":"publisher","DOI":"10.5301\/ejo.5000563"},{"key":"bibr19-ejo.5000920","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1988.01060130815029"},{"issue":"7","key":"bibr20-ejo.5000920","first-page":"870","volume":"131","author":"Baker CW","year":"2013","journal-title":"Macular edema after cataract surgery in eyes without preoperative central-involved diabetic macular edema. JAMA Ophthalmol"},{"issue":"2","key":"bibr21-ejo.5000920","first-page":"316","volume":"123","author":"Chu CJ","year":"2016","journal-title":"Risk Factors and Incidence of Macular Edema after Cataract Surgery: A Database Study of 81984 Eyes. Ophthalmology"},{"key":"bibr22-ejo.5000920","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0b013e3182979b9e"},{"key":"bibr23-ejo.5000920","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0b013e31824bebb8"},{"key":"bibr24-ejo.5000920","doi-asserted-by":"publisher","DOI":"10.1089\/jop.2011.0069"},{"issue":"10","key":"bibr25-ejo.5000920","first-page":"836","volume":"60","author":"Wahab S","year":"2010","journal-title":"J Pak Med Assoc"},{"key":"bibr26-ejo.5000920","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0b013e3182006da1"},{"issue":"3","key":"bibr27-ejo.5000920","first-page":"309","volume":"125","author":"Kuppermann BD","year":"2007","journal-title":"Randomized controlled study of an intravitreous dexamethasone drug delivery system in patients with persistent macular edema. Arch Ophthalmol"},{"key":"bibr28-ejo.5000920","doi-asserted-by":"publisher","DOI":"10.5301\/ejo.5000375"},{"key":"bibr29-ejo.5000920","doi-asserted-by":"publisher","DOI":"10.3928\/23258160-20150101-09"},{"key":"bibr30-ejo.5000920","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2012.08.002"},{"issue":"10","key":"bibr31-ejo.5000920","first-page":"1904","volume":"121","author":"Boyer DS","year":"2014","journal-title":"Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema. Ophthalmology"},{"issue":"6","key":"bibr32-ejo.5000920","first-page":"1134","volume":"117","author":"Haller JA","year":"2010","journal-title":"Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion. Ophthalmology"},{"key":"bibr33-ejo.5000920","first-page":"150","volume":"15","author":"Augustin AJ","year":"2015","journal-title":"Dexamethasone intravitreal implant in previously treated patients with diabetic macular edema: subgroup analysis of the MEAD study. BMC Ophthalmol"},{"issue":"15","key":"bibr34-ejo.5000920","volume":"54","author":"Gusson E","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["European Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.5301\/ejo.5000920","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.5301\/ejo.5000920","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.5301\/ejo.5000920","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T19:40:48Z","timestamp":1777405248000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.5301\/ejo.5000920"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,16]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,6,26]]}},"alternative-id":["10.5301\/ejo.5000920"],"URL":"https:\/\/doi.org\/10.5301\/ejo.5000920","relation":{},"ISSN":["1120-6721","1724-6016"],"issn-type":[{"value":"1120-6721","type":"print"},{"value":"1724-6016","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,16]]}}}